- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/10 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 239/10
Total number of patents in this class: 111
10-year publication summary
|
11
|
1
|
7
|
5
|
4
|
3
|
6
|
6
|
13
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3325 |
4 |
| Abbvie Inc. | 1800 |
4 |
| The Regents of the University of California | 19961 |
3 |
| F. Hoffmann-La Roche AG | 7947 |
2 |
| Abbott Laboratories | 2402 |
2 |
| FUJIFILM Corporation | 29437 |
2 |
| Board of Regents, The University of Texas System | 5808 |
2 |
| University of Southern California | 2110 |
2 |
| ADAMA Agan Ltd. | 375 |
2 |
| Aposense Ltd. | 34 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| Dong-A Pharmaceutical Co., Ltd. | 82 |
2 |
| Dr. Reddy's Laboratories Limited | 555 |
2 |
| Melior Pharmaceuticals I, Inc. | 25 |
2 |
| Purdue Pharmaceutical Products L.P. | 29 |
2 |
| Ra Pharmaceuticals, Inc. | 46 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2855 |
2 |
| University of Tsukuba | 616 |
2 |
| Vitae Pharmaceuticals, Inc. | 96 |
2 |
| Other owners | 66 |